UKDrugTesting Surface Drug Test Kit For White Powders DOA-11104-011

Key features of the white powder & surface drug testing kit

• Designed for use across a wide range of environments including workplaces, shared vehicles, offices, retail premises, clubs, pubs, festivals, and private homes.
• Each drug test kit is individually foil wrapped to maintain integrity and shelf life. Surface wipe and residue drug tests are available in single units, small packs, or bulk boxes of 25 for professional use.
• Suitable for screening unknown white powders, crystalline substances, crushed tablets, plant material, tobacco, and environmental residues. Common applications include testing worktops, keyboards, toilets, door handles, and other shared surfaces for drug contamination.

Substances detected by this multi-panel drug test kit

• Amphetamines AMP – 1000 ng/mL
• Benzodiazepines (e.g. Xanax) BZO – 300 ng/mL
• Cocaine & crack cocaine COC – 300 ng/mL
• Ketamine KET – 1000 ng/mL
• Ecstasy / MDMA MDMA – 500 ng/mL
• Methamphetamine MET – 1000 ng/mL
• Opiates (heroin, morphine, codeine) OPI – 2000 ng/mL
• Fentanyl FEN – 100 ng/mL
• Nitazenes NTZ – 2000 ng/mL
• Xylazine XYL – 1000 ng/mL

These 10-panel powder drug testing kits are engineered to detect a broad spectrum of substances most commonly encountered in white powder or crystalline form. They are widely used for drug testing in nightlife settings, festivals, harm-reduction initiatives, and occupational safety programmes, where visual identification of substances is unreliable and risk of adulteration is high.

1. Amphetamines (1000 ng sensitivity)
   Amphetamines are stimulant drugs often encountered as speed or mis-sold powders. They can increase alertness and energy but are associated with cardiovascular stress, anxiety, and dependence. Screening helps identify stimulant exposure and reduces the risk of unintended ingestion.
2. Benzodiazepines (300 ng sensitivity)
   Benzodiazepines are central nervous system depressants that may be illicitly mixed into powders. When combined with alcohol or opioids, they significantly increase overdose risk. The low detection threshold supports identification of hidden sedatives.
3. Cocaine / crack cocaine (300 ng sensitivity)
   Cocaine remains one of the most frequently searched and tested substances. As a white powder drug, it is often cut with levamisole or synthetic compounds. Reliable cocaine testing is essential for both workplace drug testing and harm-reduction use.
4. Ketamine (1000 ng sensitivity)
   Ketamine is a dissociative drug increasingly encountered in powder form. Due to dosing risks and its prevalence in club environments, ketamine drug testing is now considered a core requirement in modern testing kits.
5. MDMA / ecstasy (500 ng sensitivity)
   MDMA is commonly sold as both tablets and powder, but many products sold as “ecstasy” contain little or no MDMA. Testing helps identify genuine MDMA and reduce exposure to substituted stimulants.
6. Methamphetamine (1000 ng sensitivity)
   Methamphetamine is a potent stimulant found as powder, crystals, or pressed tablets. Given its high dependency potential and circulation in illicit markets, meth testing plays an important role in drug safety screening.
7. Opiates (2000 ng sensitivity)
   This panel detects heroin, morphine, and codeine. Opiate drug testing remains essential due to the continued risk of overdose and substitution with stronger synthetic opioids.
8. Fentanyl (100 ng sensitivity)
   Fentanyl is an extremely potent synthetic opioid frequently found as an adulterant in cocaine, heroin, and MDMA. High-sensitivity fentanyl testing is critical, as very small quantities can be fatal.
9. Nitazenes (2000 ng sensitivity)
   Nitazenes are emerging synthetic opioids, some more potent than fentanyl. Their unpredictable strength makes nitazene drug testing increasingly important for contemporary drug screening.
10. Xylazine (1000 ng sensitivity)
    Xylazine, a veterinary sedative, is often detected alongside opioids. While not an opioid itself, it significantly increases health risks and complicates overdose response.

By covering stimulants, opioids, and sedatives, these powder and surface drug test kits provide a practical solution for identifying cocaine, MDMA, ketamine, fentanyl, and other high-risk substances quickly and accurately.

How to test a white powder or residue for drugs

Each professional drug testing kit includes clear instructions. A demonstration video is also available for visual guidance.

1. Remove the drug test panel from the sealed foil pouch.

2. Lightly dip the absorbent wicks into the powder, crystal, or residue to be tested. The compact size allows access to small bags or confined areas.

3. Place the wicks into a small amount of clean water for approximately 15 seconds. Do not submerge the plastic casing, as this may invalidate the result.

4. Use clean, uncontaminated water. Avoid sources containing bleach, disinfectants, or oxidising agents. Approximately 5 ml in a sterile container is recommended.

5. Observe the test windows as the liquid migrates through the panel.

The test may also be used with urine, saliva, or other liquid samples to screen for MDMA, ketamine, and cocaine.

QR-code access to full instructions

A QR code is printed on each foil pouch, linking directly to the instructions for use and technical data sheet. This allows instant access to guidance via smartphone without additional paperwork.

Interpreting the drug test results

1. Read results between 5 and 10 minutes after activation.
2. Each strip displays a control (C) line and a test (T) line. The control line confirms the test has functioned correctly.

• Negative result: Two visible lines – one in the C region and one in the T region.
• Positive result: One line only in the C region.
• Invalid result: No line in the C region. Repeat the test with a new device.

Instructional video: how to use the surface drug test kit